Is SFIIF or MRK a better dividend investment in 2026?

SFIIF currently yields 1845.02% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SFIIF offers higher current income.

What is the dividend yield difference between SFIIF and MRK?

SFIIF has a forward dividend yield of 1845.02% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1842.26 percentage points.

Home › Compare › SFIIF vs MRK

SFIIF vs MRK: Dividend Comparison 2026

SFIIF yields 1845.02% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SFIIF wins by $4699362974.74M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SFIIF

● Live price

1845.02%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4699362974.80M

Annual income

$4,246,592,921,056,401.50

Full SFIIF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SFIIF vs MRK

📍 SFIIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SFIIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SFIIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SFIIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SFIIF

Annual income on $10K today (after 15% tax)

$156,826.57/yr

After 10yr DRIP, annual income (after tax)

$3,609,603,982,897,941.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SFIIF beats the other by $3,609,603,982,889,612.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SFIIF + MRK for your $10,000?

SFIIF: 50%MRK: 50%

100% MRK50/50100% SFIIF

Portfolio after 10yr

$2349681487.43M

Annual income

$2,123,296,460,533,099.80/yr

Blended yield

90.37%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SFIIF

No analyst data

Altman Z

-3.4

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SFIIF buys

MRK buys

No recent congressional trades found for SFIIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSFIIFMRK

Forward yield	1845.02% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$4699362974.80M ✓	$56.8K
Annual income after 10y	$4,246,592,921,056,401.50 ✓	$9,798.13
Total dividends collected	$4667018241.92M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SFIIF vs MRK ($10,000, DRIP)

Year	SFIIF Portfolio	SFIIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$195,202	$184,501.85	$11,206	$366.19	+$184.0K → SFIIF
2	$3,574,763	$3,365,897.25	$12,650	$502.35	+$3.56M → SFIIF
3	$61,432,684	$57,607,687.14	$14,407	$694.19	+$61.42M → SFIIF
4	$990,961,188	$925,228,216.73	$16,585	$967.82	+$990.94M → SFIIF
5	$15,008,659,578	$13,948,331,105.96	$19,342	$1,363.89	+$15008.64M → SFIIF
6	$213,494,078,504	$197,434,812,755.59	$22,913	$1,947.19	+$213494.06M → SFIIF
7	$2,853,164,107,573	$2,624,725,443,573.98	$27,662	$2,823.89	+$2853164.08M → SFIIF
8	$35,835,306,472,323	$32,782,420,877,219.97	$34,159	$4,173.35	+$35835306.44M → SFIIF
9	$423,149,582,939,598	$384,805,805,014,212.75	$43,337	$6,308.80	+$423149582.90M → SFIIF
10	$4,699,362,974,801,771	$4,246,592,921,056,401.50	$56,776	$9,798.13	+$4699362974.74M → SFIIF

SFIIF vs MRK: Complete Analysis 2026

SFIIF — Stock

Beonic Limited, a software technology company, provides data analytics services in Asia Pacific, the Americas, Europe, the Middle East, and Africa. The company operates through its AI Beonic Platform that transforms physical spaces into responsive environments that adapt to evolving visitor needs. It also offers data services, marketing services, managed services, and solution consulting. The company offers its solutions to airports, cities and municipalities, education, hospitality, QSR, shopping centres, stadiums and events, and retail industries. The company was formerly known as Skyfii Limited and changed its name to Beonic Limited in November 2023. The company is headquartered in Surry Hills, Australia.

Full SFIIF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SFIIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SFIIF vs SCHD SFIIF vs JEPI SFIIF vs O SFIIF vs KO SFIIF vs MAIN SFIIF vs JNJ SFIIF vs ABBV SFIIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.